We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

157 hedge funds and large institutions have $1.19B invested in Keryx Biopharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 73 increasing their positions, 28 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 28

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

46% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 24

10% more capital invested

Capital invested by funds: $1.08B → $1.19B (+$107M)

7% more funds holding

Funds holding: 147 → 157 (+10)

14% less call options, than puts

Call options by funds: $10.5M | Put options by funds: $12.2M

Holders
157
Holders Change
+10
Holders Change %
+6.8%
% of All Funds
4.18%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
35
Increased
73
Reduced
28
Closed
24
Calls
$10.5M
Puts
$12.2M
Net Calls
-$1.72M
Net Calls Change
-$5.57M

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$52.5M
2
BGIM
Brandywine Global Investment Management
Pennsylvania
+$24.7M
3
FC
Finepoint Capital
Massachusetts
+$20.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.8M
5
Franklin Resources
Franklin Resources
California
+$17.8M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$10.4M
2
PC
PointState Capital
New York
-$7.08M
3
DM
Deerfield Management
New York
-$5.37M
4
Victory Capital Management
Victory Capital Management
Texas
-$5.17M
5
Allianz Asset Management
Allianz Asset Management
Germany
-$4.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
151
Gemmer Asset Management
California
$2K +$450 +35 +23%
TDC
152
Thompson Davis & Co
Virginia
$2K +$1.79K +139 New
SEI Investments
153
SEI Investments
Pennsylvania
$2K +$2.25K +175 +398%
FPFS
154
First Personal Financial Services
North Carolina
$1K – – –
FNBOO
155
First National Bank of Omaha
Nebraska
$121 +$146K +11,340 New
CIM
156
Cambria Investment Management
California
$3 – – –
PC
157
PointState Capital
New York
– -$7.08M -500,000 Closed
Allianz Asset Management
158
Allianz Asset Management
Germany
– -$4.68M -330,892 Closed
HCMT
159
Highland Capital Management (Texas)
Texas
– -$3.37M -237,822 Closed
HM
160
HealthCor Management
New York
– -$2.52M -178,300 Closed
PP
161
PDT Partners
New York
– -$2.33M -164,350 Closed
ARTA
162
A.R.T. Advisors
New York
– -$2.23M -157,314 Closed
N
163
Nuveen
North Carolina
– -$1.84M -130,134 Closed
Dimensional Fund Advisors
164
Dimensional Fund Advisors
Texas
– -$1.28M -90,792 Closed
AQR Capital Management
165
AQR Capital Management
Connecticut
– -$1.02M -72,379 Closed
GH
166
GAM Holding
Switzerland
– -$623K -44,000 Closed
ICAP
167
Independence Capital Asset Partners
Colorado
– -$509K -36,000 Closed
SCM
168
Stevens Capital Management
Pennsylvania
– -$364K -25,699 Closed
EWM
169
Edge Wealth Management
New York
– -$285K -20,000 Closed
SCM
170
Sterling Capital Management
North Carolina
– -$267K -18,878 Closed
WMSA
171
Weiss Multi-Strategy Advisers
New York
– -$142K -10,000 Closed
SG Americas Securities
172
SG Americas Securities
New York
– -$136K -9,610 Closed
William Blair & Company
173
William Blair & Company
Illinois
– -$127K -9,000 Closed
MCM
174
Manchester Capital Management
Vermont
– -$121K -8,580 Closed
MTIP
175
Magee Thomson Investment Partners
California
– -$99K -7,057 Closed
4 5 6
7
8

KERX Hedge Fund Activity: Q1 2015 in Review

157 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q1 2015, worth a combined $1.19B — up 9.9% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new KERX positions and 24 closed out — a net gain of 11 holders — while 73 added to existing stakes and 28 trimmed.

The largest buyer was Baupost Group, adding an estimated $52.5M. The largest seller was Eagle Asset Management, cutting an estimated $10.4M.

  • 157 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q1 2015, up from 147 in Q4 2014.
  • Funds reported $1.19B of Keryx Biopharmaceuticals Inc stock for Q1 2015, up 9.9% quarter-over-quarter.
  • 35 funds opened new Keryx Biopharmaceuticals Inc positions in Q1 2015 and 24 closed out, a net change of +11 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q1 2015 was Baupost Group, an estimated $52.5M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q1 2015 was Eagle Asset Management, an estimated $10.4M sold.

Based on aggregated 13F filings for Q1 2015.